Sophie Papa, PhD, MBBS, MRCP, King’s College London in the United Kingdom, discusses chimeric antigen receptor (CAR) T-cell therapy for patients with head and neck cancer.
Sophie Papa, PhD, MBBS, MRCP
Articles by Sophie Papa, PhD, MBBS, MRCP
Latest Updated Articles
Exploring the Potential of CAR T-Cell Therapy in Head and Neck CancerPublished: May 26th 2017 | Updated: